Introduction
Dilated cardiomyopathy (DCM) is a heterogeneous group of myocardial disease characterized by cardiac dilatation and impaired myocardial contractility 1 . Infection, Metabolic, ischemic, toxic and hereditary factors have been implicated in the disease pathogenesis. Despite intensive research to find out the cause, most of the cases are still labeled as idiopathic. Myocarditis is an inflammatory disease of the myocardium with necrosis and/or degeneration of adjacent myocytes is the most frequent cause of DCM in children as a result of a viral infection.
The natural history of disease and possible outcome of cardiomyopathy in children is difficult to predict due to heterogeneous causes and characters. A patient of DCM may be cured completely or die 2 . It is difficult to find out the therapy was also given for first two days. Blood transfusion was given to raise the Hb% level to 12 gm/dl. The patient responded dramatically to above management and discharged after two weeks with LVEF 46% and LVFS 23% on follow up all parameters were excellent. On 3 months follow up in January 2016 her LVEF raised up to 60%.
Discussion
DCM is the most common form of cardiomyopathy in children. Epidemiology and clinical cause of DCM in children are not yet clear. DCM is a disorder of heart muscle and affects ventricular systolic function, diastolic function or both. This is a myocardial dysfunction and characterized by dilated left ventricle (LV) chamber and systolic dysfunction that commonly results in congestive heart failure 5-7 . This is also the most common cause of cardiac transplantation. In infants and older children there are many causes but myocarditis is the commonest cause which leads to cardiomyopathy and heart failure. Relatively little information has been published on the incidence of DCM.
Fujioka SK et al demonstrated active Coxsackie-B virus RNA replication in the myocardium was present in a significant proportion of virus positive American and Japanese patients 5 of 7 (71.42%) and 9 of 15 (60%) respectively with end stage idiopathic dilated cardiomyopathy 8 . Another study showed incidence of DCM as 0.56 cases per 100,000 per year which is 10 times higher than adults. Boys have a higher incidence than girls and blacks have a higher incidence than whitees 9-11 .
DCM is more likely to present in the first year of age than in early or late childhood. Infants are 13 times more affected than older age group. Most common cause of infantile DCM includes idiopathic, secondary to viral myocarditis, inborn error of metabolism and deficiency of thiamine and carnitine. DCM in older age has a worse outcome. Congestive cardiac failure is common in 71% cases of DCM and associated with myocarditis and idiopathic varieties 5 . Mortality for DCM usually occurs in first two years of life. Mortality rate does not match with specific cause of cardiomyopathy. Transplantation is the specific modality of treatment but not yet possible in Bangladesh. One-third of DCM patient die, one-third cure with therapy, rest one third patient survive and require treatment throughout life. Early diagnosis, risk stratification, new therapy need to be developed for infants and children with DCM to avoid the need for transplantation and premature death 12-15 . In present case Coxsackie-B virus was detected as the cause of myocarditis which led to DCM secondary to myocarditis and patient received Intravenous Immune globulin (IVIG) with a good outcome. DCM due to thiamine and carnitine deficiency also has a good outcome after treatment. The patient received two doses of IV Immunoglobulin and her cardiac function improved within 3 months of treatment. 
Conclusion
The primary cause of DCM is unknown in most of the cases of children. The true incidence of viral-induced myocardial inflammation is difficult to predict but data from both paediatric and adult centers suggest that Coxsackie-B virus is the most common viral etiology. Other viruses that can also cause myocarditis like parvo virus B 19, Adenovirus, Cytomegalovirus (CMV) etc. Vaccination has been used successfully to prevent this disease like many viral diseases which suggest that a Coxsackie-B virus specific vaccine could be beneficial for reducing the incidence of myocarditis or DCM. The prognosis in individual patients is unpredictable. It depends on specific etiology, timely diagnosis and optimum management of heart failure and cardiac transplantation in some selected cases.
